Description
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
This trial is available at multiple Sutter Locations. Please contact one of the following about Study ECOG-ACRIN EA6134
San Francisco: ClinicalTrials@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Rodrigi@sutterhealth.org and babskik@sutterhealth.org
Modesto: MassonD@sutterhealth.org and PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: gonzals@sutterhealth.org
View study details on ClinicalTrials.gov
Principal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019